Related Experiment Video
Updated: May 18, 2026

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice
Published on: May 4, 2015
Monoamine oxidase inhibitors and neuroprotection: a review
Saleem K Al-Nuaimi1, Erin M Mackenzie, Glen B Baker
1Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
Monoamine oxidase inhibitors have been available for more than 50 years, initially developed as antidepressants but currently used in a variety of psychiatric and neurological conditions. There has been a recent surge of interest in monoamine oxidase inhibitors because of their reported neuroprotective and/or neurorescue properties. Interestingly, it seems that often these properties are independent of their ability to inhibit monoamine oxidase. This review article presents an overview of the neuroprotective/neurorescue properties of these multifaceted drugs and focuses on phenelzine, (-)-deprenyl, rasagiline, ladostigil, tranylcypromine, moclobemide, and clorgyline and their possible neuroprotective mechanisms.
Related Concept Videos
Drugs Affecting Neurotransmitter Synthesis
Antidepressant Drugs: MAOIs and Other Agents
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
The Blood-brain Barrier
